---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-24-000045"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T01:58:41.017673+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Exagen Q1 revenue up 28% to $14.4M; raises FY2024 guidance

## Summary
- Revenue $14.4M, +28.4% YoY; gross margin 59.6% vs 47.2% a year ago.
- Net loss $3.4M, a 56.3% improvement; adjusted EBITDA -$2.0M, a 67.7% improvement.
- AVISE CTD trailing 12-month ASP $377, up 35.1% versus prior year.
- Company raises full-year 2024 revenue and adjusted EBITDA guidance on strong momentum.
- Cash and equivalents $27.3M; accounts receivable $10.9M; cash runway into 2026.

## SEC filing metadata
- accession: 0001274737-24-000045
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000045/0001274737-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000045/exdx-20240513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-24-000045
- JSON: https://secwatch.observer/filing/0001274737-24-000045.json
- Plain text: https://secwatch.observer/filing/0001274737-24-000045.txt

## Key facts
- Earnings Releases
  EXAGEN INC. reported the quarter ended March 31, 2024 results: revenue $14.4 million, net income $3.4 million. Guidance raised.
  - Period: the quarter ended March 31, 2024
  - Revenue: $14.4 million
  - Net income: $3.4 million
  - Guidance: raised
  - Result: reported results
  source text: leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2024. First Quarter Highlights: • Recognized total revenue of $14.4 million in the first quarter of 2024, a 28.4% increase over the first quarter of 2023. • Delivered gross margin of 59.6% in the first quarter of 2024, compared to a gross margin of 47.2%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000045/0001274737-24-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.